ETNHX Mutual Fund

NAV$54.45

Fund Essentials - as of Dec 31, 2025

Net Assets
$83M
Expense Ratio
1.51%
Dividend Yield (Current)
-
Holdings
90
Inception Date
Dec 27, 2012
Fund Family
Eventide
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+13.39%
1 Year+71.36%
3 Year+15.52%
5 Year+6.55%
10 Year+14.96%

Asset Allocation

Stocks: 93.43%
Bonds: 0.01%
Cash: 0.22%
Other: 6.34%

Top Holdings

View All →
TickerNameWeight
GHGuardant Health, Inc4.46%
MIRMMirum Pharmaceuticals Inc3.60%
BBNXBeta Bionics Inc. Ser E3.19%
INSMInsmed Inc3.15%
-Petroleos Mexicanos 6.84% 01/23/20303.11%
Top 10 Concentration: 30.70%Report Date: Dec 31, 2025
Download all 90 holdings for ETNHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$4.36
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

ETNHX Mutual Fund Overview

ETNHX Mutual Fund (Eventide Healthcare & Life Sciences Fund Class N) is managed by Eventide with $82.9M in net assets. ETNHX expense ratio is 1.51%, holding 90 positions across sectors including Health Care, Other, Unknown. Inception date: 2012-12-27.

ETNHX performance shows a YTD return of 13.39%. The 1-year return is 71.36% and the 5-year return is 6.55%.

ETNHX top holdings include Guardant Health, Inc (4.5%), Mirum Pharmaceuticals Inc (3.6%), Beta Bionics Inc. Ser E (3.2%), Insmed Inc (3.1%), Petroleos Mexicanos 6.84% 01/23/2030 (3.1%). View all ETNHX holdings, sector breakdown, or dividend history.

ETNHX can be compared against other funds using the overlap calculator or side-by-side comparison tool. ETNHX alternatives are available via the screener, along with tax-loss harvesting opportunities.